Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Duke Studying Impact Of Clinical Trial Coverage On Enrollment For CMS

This article was originally published in The Gray Sheet

Executive Summary

With anecdotal evidence suggesting that issues surrounding insurance coverage for clinical trial treatments may hamper study participation, CMS has contracted with Duke University to conduct a more systematic evaluation of the issue

You may also be interested in...



ClinicalTrials.Gov Could Monitor Reimbursement Impact On Trials – AHRQ

Government health care agencies could use ClinicalTrials.gov to learn how third-party payment impacts enrollment in clinical trials, Duke Evidence-Based Practice Center researchers suggest in a new white paper commissioned by the Agency for Healthcare Research and Quality (AHRQ)

ClinicalTrials.Gov Could Monitor Reimbursement Impact On Trials – AHRQ

Government health care agencies could use ClinicalTrials.gov to learn how third-party payment impacts enrollment in clinical trials, Duke Evidence-Based Practice Center researchers suggest in a new white paper commissioned by the Agency for Healthcare Research and Quality (AHRQ)

Self-Certification For Trial Coverage Will Be Easy, Says CMS

CMS is trying to make it simple for clinical trial sponsors and investigators to get reimbursed by Medicare for routine costs

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025309

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel